Microbot Medical Inc.

NasdaqCM:MBOT Stock Report

Market Cap: US$47.9m

Microbot Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Harel Gadot

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage29.0%
CEO tenure15yrs
CEO ownershipn/a
Management average tenure6.8yrs
Board average tenure6yrs

Recent management updates

Recent updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Sep 01
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Dec 28
Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical acquires Nitiloop, terms undisclosed

Oct 07

Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Sep 13
Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical confirms GLP trial on track to begin later this month

Sep 02

Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Apr 23
Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier

Jan 06

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

Dec 24
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Aug 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

May 12
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Jan 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Microbot Medical's study of surgical robotic system meets endpoints

Jan 14

CEO Compensation Analysis

How has Harel Gadot's remuneration changed compared to Microbot Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$11m

Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$1mUS$373k

-US$11m

Sep 30 2023n/an/a

-US$11m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$13m

Dec 31 2022US$2mUS$514k

-US$13m

Sep 30 2022n/an/a

-US$14m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$2mUS$534k

-US$11m

Sep 30 2021n/an/a

-US$10m

Jun 30 2021n/an/a

-US$10m

Mar 31 2021n/an/a

-US$9m

Dec 31 2020US$2mUS$450k

-US$9m

Sep 30 2020n/an/a

-US$8m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019US$1mUS$360k

-US$7m

Sep 30 2019n/an/a

-US$8m

Jun 30 2019n/an/a

-US$7m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$1mUS$360k

-US$7m

Compensation vs Market: Harel's total compensation ($USD1.28M) is above average for companies of similar size in the US market ($USD641.95K).

Compensation vs Earnings: Harel's compensation has been consistent with company performance over the past year.

CEO

Harel Gadot (51 yo)

15yrs

Tenure

US$1,284,123

Compensation

Mr. Harel Gadot is the Founder of MEDX Ventures Group LLC and serves as its Chairman. Mr. Gadot has been the Chief Executive Officer and President of Microbot Medical Inc. since November 28, 2016 and its C...

Leadership Team

NamePositionTenureCompensationOwnership
Harel Gadot
Co-Founder15yrsUS$1.28mno data
Yoseph Bornstein
Co-Founder & Independent Director15yrsUS$74.12k0%
$ 0
Rachel Vaknin
Chief Financial Officer2.8yrsUS$289.50k0%
$ 0
Simon Sharon
CTO & GM of Microbot Israel6.8yrsUS$469.93k0%
$ 0
Juan Diaz-Cartelle
Chief Medical Officer1.1yrsno data0%
$ 0

6.8yrs

Average Tenure

51yo

Average Age

Experienced Management: MBOT's management team is seasoned and experienced (6.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Harel Gadot
Co-Founder10.5yrsUS$1.28mno data
Yoseph Bornstein
Co-Founder & Independent Director8.2yrsUS$74.12k0%
$ 0
Scott Burell
Independent Director8.2yrsUS$76.00k0%
$ 0
Ajay Wakhloo
Member of Scientific Advisory Board3yrsno datano data
Stephen Solomon
Member of Scientific Advisory Board3yrsno datano data
Tal Wenderow
Independent Director4.5yrsUS$73.70k0%
$ 0
Giora Weisz
Member of Scientific Advisory Board3yrsno datano data
Martin Madden
Independent Director7.9yrsUS$76.00k0%
$ 0
Prattipati Laxminarain
Independent Director7.1yrsUS$72.25k0%
$ 0
Eyal Morag
Member of Scientific Advisory Board7.2yrsUS$511.87kno data
Aileen Stockburger
Independent Director4.8yrsUS$75.01k0%
$ 0
Dmitry Rabkin
Member of Scientific Advisory Board3yrsno datano data

6.0yrs

Average Tenure

60.5yo

Average Age

Experienced Board: MBOT's board of directors are considered experienced (6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 15:36
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Microbot Medical Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuH.C. Wainwright & Co.
Jeffrey CohenLadenburg Thalmann & Company